Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.180
+0.010 (0.46%)
Jun 17, 2026, 4:00 PM EDT - Market closed
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nautilus Biotechnology stock have an average target of $4.00, which predicts a 83.49% increase from the current stock price of 2.18.
Price Target: $4.00 (+83.49%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 29, 2026.
Analyst Ratings
The average analyst rating for Nautilus Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Oct '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $4 | Buy | Reiterates | $4 | +83.49% | Apr 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 28, 2026 |
Financial Forecast
Revenue This Year
700.00K
Revenue Next Year
7.65M
from 700.00K
Increased by 992.86%
EPS This Year
-0.61
EPS Next Year
-0.60
from -0.61
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 900,000 | ||
| Avg | 700,000 | ||
| Low | 500,000 |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 1,400.0% | |
| Avg | 992.9% | |
| Low | 585.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.61 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |